1. Agilent Technologies Discovery Begins with Measurement January 8, 2014 1

2. Wireless technologies Mobile phone R&D and manufacturing Aerospace/defense systems and maintenance Computer & industrial research & manufacturing Food safety, quality Energy research, production Quality of air, water, soil Forensics, drugs of abuse Pharmaceutical research and manufacturing Academic and government research Cancer diagnostics Cytogenetics research Genomics tools for molecular analysis Agilent Technologies 2 Addressing critical measurement challenges Electronic Measurement Group Chemical Analysis Group Life Sciences and Diagnostics Group FY13 Revenue: $6.8B FY13 Revenue* $2.3B FY13 Revenue $1.6B FY13 Revenue $2.9B *represents the sum of the former DGG and LSG revenues January 8, 2014

3. Agilent at a Glance 3 REVENUE IN FY13 $6.8 billion (more than 70% generated outside the U.S.) EMPLOYEES 20,600 PRESIDENT & CEO, AGILENT William P. (Bill) Sullivan EXECUTIVE VP, AGILENT; PRESIDENT & CEO, KEYSIGHT TECHNOLOGIES Ron Nersesian CUSTOMER LOCATIONS 100+ countries MANUFACTURING AND R&D LOCATIONS U.S., Europe, Asia Pacific NYSE A January 8, 2014

4. Agilent FY13 Revenue Distribution 4 By region January 8, 2014

5. Agilent FY13 Revenue Distribution 5 By end markets Aerospace/Defense: 10% Industrial/Computers/ Semiconductors: 18% Chemical/Energy: 14% Forensics/Environmental: 9% Food: 6% Pharma/Biotech: 15% Academia/Gov’t: 7% Diagnostics/Clinical: 7% January 8, 2014

6. Two Great Companies from One Agilent announced Sept. 19, 2013, it will separate into: a Life Sciences, Diagnostics and Applied Markets company (to retain the Agilent name) an Electronic Measurement company (with a new name) Separation expected in early November 2014, subject to local legal procedures. 6 January 8, 2014

7. When Separated... 7 Agilent’s Electronic Measurement business will be called... January 8, 2014

8. Business Rationale for the Separation Agilent has evolved into two distinct investment and business opportunities. As two separate companies, each will be able to direct resources to its own business and customer needs. Each company has the operational and financial scale to stand on its own. The companies can concentrate solely on distinct markets and growth drivers. Both companies are well positioned to maximize growth. 8 January 8, 2014

9. A Snapshot of the Two Companies 9 Each company will be independently managed and publicly traded Pharma & biotech Academia & government research Food Environmental & forensics Chemical & energy Anatomic pathology Molecular diagnostics President and CEO Bill Sullivan $3.9* billion Agilent Communications Industrial, computer & semiconductor Aerospace/defense President and CEO Ron Nersesian $2.9* billion Keysight January 8, 2014 *per company estimate

10. A Brief History of Agilent 10 Our journey so far 1939–1998: The Hewlett-Packard years 60-year heritage of leadership and innovation 1999: Agilent is born Biggest IPO in Silicon Valley: $2.1 billion 2005: The new Agilent Focus on measurement 2006–2010: Transformation Acquisitions, divestitures and restructuring 2013: World’s premier measurement company $6.8 billion revenue 2013: Agilent announces separation Expected to be two companies in early November 2014 2014: EM business named Keysight Technologies January 8, 2014